Correlation of rejection episodes with FK 506 dosage, FK 506 level, and steroids following primary orthotopic liver transplant by Jain, AB et al.
/~Tt/ 
Correlation of Rejection Episodes With FK 506 Dosage, FK 506 Level, 
and Steroids Following Primary Orthotopic Liver Transplant 
A.B. Jain. S. Todo. J.J. Fung, A. Venkataramanan. A. Day. J. Bryant. K.M. Abu-Elmagd, M. Alessiani. 
S. Takaya. A. Tzakis. and T.E. Slarzl 
L ESS frequent and less severe rejection following 
orthotopic liver transplants IOL T) under FK S06 has 
been reported earlier from our institution. 1.2 In the present 
study. the frequency of episodes of rejection were corre-
lated with: (I) IV FK S06 dosage. (2) oral FK S06 dosage. 
(3) trough FK 506 plasma concentrations. and (4) use of 
steroids following primary OLT in a group of patients who 
experienced rejection episodes. and to compare them with 
a group who did not experience any rejection episodes. 
MATERIAL AND METHODS 
One hundred ten adults (mean ~ SO: 46.2 ± 12.4 yean: 58 male. 
52 female I Wllh pnmary OlT were selected. Fint. a 9O-day 
posllransplant penod was chosen for study purposes. since the 
majority of rejection (approximately 90%) generaUy occurs in this 
time period. Six patients who underwent retransplants III - 5) or 
died (II = I) within 10 days after transplant were excluded from 
the analysis. 
FK506 
Protocol. All patients were commenced on LV FK 506 (0.15 
mgtkg per dav) in two divided doses. This dose was hiller than the 
current fK 506 dose (which is 0.1 m8lk8 per day). and was given 
over 24-hour continuous infusion. Subsequent adjustments in 
doses were made depending on the trough levels. hepatic func· 
tlon. renal function. Side effects from the drug. historY of rejec· 
tlon. or presence of infection. 
Steroids 
Hif(h PrnphyltUis SltrOld Group. Of the 104 pauents available 
for analysis. 53 patients received 1 g of methyl prednisone after 
perfusion of the liver. then 200 mg In four divided doses was given 
on the first postoperative day. The dose was reduced by 40 mg 
every day until a 20 m8ld baseline maanlenance dose was reached. 
:OK' ProphvltUlS Sitroid Group. The reltWning S I patients 
received only 20 m8ld of methylpredrusone. Subsequent adjust-
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~ 1. Graphical representatlon of ePISOdes of rejectIOn (.) With 
oral FK 506 dose over time. pumU1~ line toins the median 
covanate of oral FK 506 dose over bme for nonrelector. 
ment in baseline steroid dose was made on an individual basis In 
relation to the clinical coune of the pallent. 
Rejection 
The diagnOSIS of rejecuon was made by nses In serum bilirubin 
and hepatic enzymes an the absence of biliary compllcauons. 
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Fig 2. Graphic representalJOn of ePISOdes of relectlOn (.) with FK 
506 trough plasma level (nglmL) over time (days). Supenmposed 
line lOins the median covanate of FK 506 level over time lor 
nonrelector. 
ischemic damage. or development of hepatitis (hepatitis B. non-A. 
non·B. or cvtometlalovlrus (CMVjl. In addition. all the patients 
had protocol biopsies at 10 to 1-1 da\'s posttransplant. and subse· 
quenth' If clinlcallv indicated. 
Statistical Methodology 
For each patient. daily doses of IV FK S06. oral FK 506. FK S06 
trough levels. and daily dose of steroids were recorded. A format 
test of the relationship of the following four vanables to organ 
rejection was carned out: (1l1V FK 506.12l. oral FK 506. Ol FK 
506 troutlh plasma levels. and (4) baseline steroids: a proponlonal 
hazards model wnh time·varylng covanates was used. Time-
Independent covanate of inillal prophylaXIS stcrOid uose and I V 
FK 506 were also examined. The data were 31so examaned 
graphtcall\' to see whether any obVIOUS panem clustcd. 
RESULTS 
Elfects ot FK 506 Dosage (IV ... oral). FK 506 Trough 
Plasma Levels. and Baseline Steroids 
Of 104 pallents. ~ expenenced episodes of rejecllon 
within the 9O-day posttransJ)lant J)eriod. The median FK 
506 dose at the time of rejection was 0.207 mglkg per day 
while. at the same lime. an the nonrejectlon groUJ). it was 
0.199 mglkg J)er day. The median FK 506 level J)rior to 
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Fig 3. Graphic representation of episode of rejection (.) With 
prednisone dose {mgld) over time (days). Supenmposed hne Joins 
the median covanate of prednisone dose over time tor nonrelector. 
rejection was 1.05 ng/mL comJ)ared with 0.9 ng/mL for the 
nonrejecting patients. Similarly. baseline mean steroid 
dose at the time of rejection was 14.8 mg/d (SO = 7.6) for 
patients who expenenced reJection. and 16.03 mgtd (SO = 
10.7) for those who had no rejection episodes m the same 
time J)eriod (Table I). 
The proportional hazards models with time.varving co-
variates gave no mdicallon of any relationshiJ) between the 
incidence of rejection and the values of FK 506 dose (IV 
and orall. FK 506 level. or baseline J)rednisone. for any of 
the four co variates just pnor to rejection (p = .6): nor was 
any relationship observed graphically. In Figs 1. 2. and 3. 
the covanate level of each of the 44 patients expenencmg 
rejections IS graJ)hed agatnst the lime to rejection (plotted 
with astensks I. wtlh lines supenmJ)osed joining the medtan 
covariate values over time for nonreJectors. 
Effect High-Dose SterOid PrOPhyl8XIs Versus Low-Dose IV 
FK 506 
EXJ)lorallon of the data did reveal fewer episodes of 
rejection m the grouJ) of pallents who received a high 
prophylactic dose of steroids on day I to 5 (17 of 53) (Table 
2) comJ)ared with low prophylaxis (27 of 51). This differ· 
ence. by chi·square test of aSSOCiation. is not SignIficant IP 
= .(8) as reponed beforeK~ However. if a J)roponlonal 
FK 506 REJECTION EPISODES IN OlT 
Table 2. High V .... ua Low-OoM Steroid Prophylaxis 
(Dlys 1 to 5) 
Did nor Reject (%) AIIjIaon (%1 
eigh~ose sterotd 36 (68) 17 (32) 
prophyt8Xls 
Low-dose sterOId 24 (47) 27(53) 
propttyl8XlS 
Total 60(58) 44 (42) 
Total 
53 
51 
104 
Chi-~ lest Of 8SSOCIIIIon wu nor ~ (P > .051. ~K tile 
bmH Ideoet Ide! ~ PI'OOOI1IOI1If fIaZIrcIs modIII rW¥MI • IIgI1Ific8ntIy lOwer rISk of 
r8jedlOn among recIPIents DllndllllIIgh-<IOIe ... ~ tP. OOn. 
hazards model is fit to the data with (time-independent) 
covariates of initial steroids (over days I to 5) (Table 2) and 
IV FK 506. then the initial steroid level is significantly 
related to rejection (P < .05). while initial IV FK 506 dose 
is not. 
DISCUSSION AND CONCLUSIONS 
One aim was to discover whether lowering the dose of FK 
506 increased the risk of rejection. Downward adjustments 
in FK 506 dose did not correlate significantly with the 
3025 
frequency of rejection. There were insufficient data points 
to correlate the results with FK 506 levels. 
However. the initial 5 days of high-dose of prophylactic 
steroids had an effect on the 9O-day incidence of rejection. 
This difference between high- or low-dose steroid induc-
tions was not significant by Chi-square test of association. 
but it was significant with the time-independent propor-
tional hazard model. Severity of rejection usually was mild 
and readily controlled with minor augmentation of main-
tenance steroids as reported before.:: Because of this. we 
currently do not give the 5-day course of prophylactic 
high-dose steroids to our OL T patients. except in those 
who have positive lymphocyte crossmatch or higher per-
centage of (>40%) panel-reactive antibodies. in whom 
incidence of rejection episodes are higher.J 
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